BlackRock Fund Advisors - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 52 filers reported holding SECOND SIGHT MED PRODS INC in Q3 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2016$937,000
-35.6%
475,860
+15.1%
0.00%
Q3 2016$1,455,000
+14.0%
413,438
+16.0%
0.00%
Q2 2016$1,276,000
-13.7%
356,344
+16.5%
0.00%
Q1 2016$1,478,000
-22.4%
305,968
-5.3%
0.00%
Q4 2015$1,904,000
+1.6%
323,241
+2.3%
0.00%
Q3 2015$1,874,000
-55.4%
316,003
+2.3%
0.00%
-100.0%
Q2 2015$4,205,000
+178.3%
308,968
+162.2%
0.00%
Q1 2015$1,511,000
+34.6%
117,833
+7.7%
0.00%
Q4 2014$1,123,000109,4230.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$8,536,653,0002.90%
Glassman Wealth Services 72,366$137,0000.06%
B. Riley Wealth Management, Inc. 53,500$102,0000.02%
Sigma Planning Corp 223,400$424,0000.02%
Fore Capital, LLC 40,000$76,0000.02%
Psagot Value Holdings Ltd. 218,555$415,0000.02%
HBK Sorce Advisory LLC 85,500$162,0000.02%
WealthTrust Axiom LLC 10,000$19,0000.01%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 12,894$24,0000.01%
Weiss Asset Management LP 29,691$56,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders